Ligand profile
WP7
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00305 — Glutathione reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
WP7- PDB
2wpc- UniProt (similar protein)
Q389T8- Target protein
- KP13_00305
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 52.3
- −1 ≤ LogP ≤ 5 4.85
- MW ≤ 500 Da 463.0
- LogP ≤ 5 4.85
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 52.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC1=Nc2ccc(cc2[C@@H](N1CCN3CCN(CC3)C(=O)c4ccco4)c5ccccc5)ClCC1=Nc2ccc(cc2[C@@H](N1CCN3CCN(CC3)C(=O)c4ccco4)c5ccccc5)Cl
InChI=1S/C26H27ClN4O2/c1-19-28-23-10-9-21(27)18-22(23)25(20-6-3-2-4-7-20)31(19)16-13-29-11-14-30(15-12-29)26(32)24-8-5-17-33-24/h2-10,17-18,25H,11-16H2,1H3/t25-/m0/s1InChI=1S/C26H27ClN4O2/c1-19-28-23-10-9-21(27)18-22(23)25(20-6-3-2-4-7-20)31(19)16-13-29-11-14-30(15-12-29)26(32)24-8-5-17-33-24/h2-10,17-18,25H,11-16H2,1H3/t25-/m0/s1
LZBVDXKZVXPKHV-VWLOTQADSA-NLZBVDXKZVXPKHV-VWLOTQADSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF07992
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand WP7 →
- PDB RCSB structure 2wpc →
- UniProt UniProt Q389T8 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “WP7”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00305.
PDB 23
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).